Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Scienture Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 643.8K | 537.5K | −106.3K (−16.5%) |
| Value | $1.52M | $1.49M | −$27.0K (−1.8%) |
New holders (3)
Institutions that held Scienture Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 11,624 | $32.0K | 0.00% |
| UBS Group AG | 3,072 | $9.00K | 0.00% |
| Citigroup Inc | 300 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Scienture Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 21,600 | $51.0K |
| Susquehanna International Group, LLP | 21,335 | $50.0K |
| Virtu Financial LLC | 17,447 | $41.0K |
| Morgan Stanley | 5,248 | $12.0K |
| Bank of America Corp | 6 | $0 |